Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Cost-utility Analysis of the Use of the Paro Robotic Seal by Elderly Patients With Moderate or Severe Cognitive Disorders in Institutions: a Randomised Study.

NCT04941222 · Centre Hospitalier Departemental Vendee · Updated 23 Sept 2025

What is being tested
With robotic seal "PARO"
For
Cognitive Impairment
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 70 years and older. About 33 people. The full rules are on the registry page.
Where
France
When
Starts or started 29 July 2021, ends 5 April 2023. Registered 28 June 2021.
Results
None posted yet.

In the researchers' words

Many residents from establishments for dependent elderly people (EHPAD) have memory disorders with behavioural problems such as agitation, aggression and anxiety, which make it difficult to assist them on a daily basis. Studies have proven the beneficial effect of the therapeutic seal robot PARO® in behavioural disorders. The present project aims to complement these data with a medico-economic study. At present, the only study of this type has been carried out in Australia, and is not transposable to France.
ClinicalTrials.gov, NCT04941222

Sites

  • CHD VendeeLa Roche-sur-Yon, France